Lv3
202 积分 2024-10-07 加入
中国髓外浆细胞瘤诊断与治疗专家共识
2天前
已完结
In multiple myeloma increased thrombopoietin (Tpo) production may be involved in the maintenance of platelet production
9天前
已完结
Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes
9天前
已完结
Platelet hyporeactivity in active myeloma
9天前
已完结
Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation
9天前
已完结
Development and Validation of a Simplified Score to Predict Early Relapse in Newly Diagnosed Multiple Myeloma in a Pooled Dataset of 2,190 Patients
16天前
已完结
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma
16天前
已完结
Clinical and genomic characterization of Chinese patients with functional high-risk multiple myeloma: A real-world validation study
17天前
已完结
European Myeloma Network Consensus Statement on Functional High‐Risk Multiple Myeloma
28天前
已完结
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial
1个月前
已关闭
皖公网安备34019202002308
